Advanced manufacturing
Genentech Holly Springs Manufacturing Facility
Holly Springs, North Carolina
Project overview
Genentech is constructing its first East Coast manufacturing facility for next-generation metabolic treatments using advanced automation and digital production technology.
- Scope
- Genentech is constructing its first East Coast manufacturing facility for next-generation metabolic treatments using advanced automation and digital production technology.
- Project type
- Biopharmaceutical manufacturing
- Reported investment / scope
- Approximately $2 billion
- Funding sources
- Not available
- Delivery method
- Not available
Organizations involved
- Owner / developer
- Genentech; Roche
- Developer
- Not available
- Engineering firm / architect
- Not available
- General contractor / construction manager
- Not available
- EPC contractor
- Not available
- Technology / equipment providers
- Not available
- Financial sponsor
- Not available
- Other recorded participants
- Not available
Business opportunities
Not verified
- Current procurement record
- Not available
- Upcoming procurement
- Not available
- Contract / package value
- Not available
- Supplier / subcontractor opportunities
- Not available
- Workforce requirements
- Not available
Check official project / procurement portal ↗
A project listing is not an open solicitation. Check the source for eligibility, current status, closing time and addenda.
Timeline & key dates
- Expected procurement
- Not available
- Construction start
- Not available
- Estimated completion
- Not available
- Dated milestones
- Not available
- Permitting
- Not available
- Recent project updates
- The manufacturing building reached structural topping out on August 18, 2026.
- Challenges / risks
- Not available
Related intelligence
No verified record associations have been entered for this project yet.
Connections use recorded entity IDs and public evidence. Shared keywords do not establish a relationship.
Additional project record
Owner: Genentech; Roche
Location: Holly Springs, North Carolina
Sector: Advanced Manufacturing
Stage: Construction
Genentech is constructing its first East Coast manufacturing facility for next-generation metabolic treatments using advanced automation and digital production technology.
Reported investment: Approximately $2 billion
Verified project update
The manufacturing building reached structural topping out on August 18, 2026.
Reviewed October 1, 2026. Status and targets reflect the cited source; anticipated dates are subject to change.
Saved searches & recent searches
Sign in to keep searches across devices. Your recent searches on this device appear below.
Join Infraday Free · Sign in